| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |